HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of the tumor-bearing host serum on the leukocyte adherence inhibition reaction mediated by immune RNA].

Abstract
51Cr-labelled leucocyte adherence inhibition (LAI) assay was used as an index to study the activity of xenogenic immune RNA (iRNA) in inducing normal LACA mouse spleen lymphocytes to mediate tumor specific response in vitro. RNA was extracted from the spleen and lymph nodes of the guinea pigs immunized by S180 or H22 ascitic tumor cells and from those of the normal guinea pigs. Extracts of S180 or H22 tumor cells and that of normal LACA mouse livers were prepared by PBS method respectively. Three kinds of RNA and three kinds of cell (tissue) extracts were grouped into nine combinations. A defined number of 51Cr-labelled lymphocytes was added to each group. The results showed that only in the combination of two kinds of iRNA and the corresponding tumor cell extract, adherence of normal lymphocyte was significantly inhibited. Serum from tumor bearing host inhibited LAI reaction mediated by iRNA. The "blocking" effect was specific since it occurred only when the serum and tumor extract in the reaction system were taken from the same tumor-bearing donor.
AuthorsX M Wang, C J Wang, C Z Su
JournalZhonghua zhong liu za zhi [Chinese journal of oncology] (Zhonghua Zhong Liu Za Zhi) Vol. 9 Issue 2 Pg. 106-8 (Mar 1987) ISSN: 0253-3766 [Print] China
PMID2443326 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • RNA, Neoplasm
  • RNA, immune
  • RNA
Topics
  • Animals
  • Antigens, Neoplasm (immunology)
  • Carcinoma, Ehrlich Tumor (immunology)
  • Guinea Pigs
  • Leukocyte Adherence Inhibition Test
  • Lymphocytes (immunology)
  • Male
  • Mice
  • RNA (immunology)
  • RNA, Neoplasm (immunology)
  • Sarcoma 180 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: